Fluorometholone Acetate (formerly NSC47438; NSC-47438; U 17,323; AI 3-52814; Flarex) is a synthetic corticosteroid that has been approved as a medication commonly used as eye drops in the treatment of steroid responsive inflammatory conditions of the eye.

Clevidipine (Cleviprex) is a potent and short acting, dihydropyridine-based L-type calcium channel blocker used for reducing blood pressure when oral therapy is not feasible or not desirable.

Diltiazem HCl (Tiazac, RG-83606 HCl) is a benzothiazepine derivative and a calcium-channel blocker (CCB) with vasodilating activity.

Azumolene is a potent muscle relaxant that inhibits the release of calcium from skeletal muscle sarcoplasmic reticulum.

Verapamil is a novel and potent calcium channel blocker.

YM-58483, formerly known as BTP 2, is a potent inhibitor of CRAC channels, blocking thapsigargin-induced sustained calcium influx, Th2 cytokine production, and NF-AT-driven promoter activity in T lymphocytes (IC50 = 100 nM).

Nifedipine D6 is the hexa-deuterated form of Nifedipine (Bay-1040; Cordipin; BAY-a-1040; Corinfar) which is an approved antihypertensive drug of the dihydropyridine calcium channel blocker (CCB) class.

Mirogabalin (DS-5565) is a potent, selective and orally bioavailable α2δ-1 ligand under development for treating pain associated with diabetic peripheral neuropathy, fibromyalgia, and postherpetic neuralgia.

Imperatorin is a novel and potent furocoumarin and phytochemicals.

Meprednisone (formerly NSC-527579; SCH-4358; NSC63278; SCH4358; Betapar; Medrysone) is a glucocorticoid and a methylated derivative of prednisone acting as a glucocorticoid receptor agonist and has been approved for use to treat allergic and inflammatory of the eye.